Frederic Guerard's Insider Trades & SAST Disclosures
Frederic Guerard's most recent trade in CalciMedica Inc was a trade of 10,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 27, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Frederic Guerard.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CalciMedica Inc | Frederic Guerard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| CalciMedica Inc | Frederic Guerard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| LENZ Therapeutics Inc. | Frederic Guerard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 30,897 | 30,897 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Frederic Guerard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Frederic Guerard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 23,571 | 23,571 | - | - | Stock Option (right to buy) | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 83,705 | 111,110 | - | - | Common Stock | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 83,705 | 0 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.50 per share. | 23 Mar 2023 | 20,383 | 90,727 | - | 5.5 | 112,107 | Common Stock |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 315,496 | 473,026 | - | - | Common Stock | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 221,746 | 0 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 03 Mar 2023 | 89,344 | 383,682 | - | 0.6 | 50,926 | Common Stock |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 65,625 | 918,750 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 28,125 | 253,125 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 28,125 | 281,250 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 28,125 | 168,598 | - | - | Common Stock | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. | 01 Dec 2022 | 11,068 | 157,530 | - | 0.6 | 6,973 | Common Stock |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2022 | 65,625 | 984,375 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2022 | 65,625 | 166,297 | - | - | Common Stock | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 24 Nov 2022 | 25,824 | 140,473 | - | 0.7 | 17,302 | Common Stock |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2022 | 1,050,000 | 1,050,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 28,125 | 309,375 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 28,125 | 107,268 | - | - | Common Stock | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 19 Aug 2022 | 6,596 | 100,672 | - | 1.0 | 6,398 | Common Stock |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 112,500 | 337,500 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 112,500 | 112,500 | - | - | Common Stock | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 19 May 2022 | 33,357 | 79,143 | - | 0.9 | 30,058 | Common Stock |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 221,746 | 221,746 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 170,054 | 170,054 | - | - | Employee Stock Option (Right to Buy) | |
| CalciMedica Inc | Frederic Guerard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges